McKesson Closer To Resolving Multi-Year AWP Legal Saga With $190M Federal Settlement
This article was originally published in The Pink Sheet Daily
Executive Summary
Wholesale drug distributor McKesson settles charges that it reported inflated average wholesale prices (AWPs) for a large number of branded prescription pharmaceuticals, leading to extensive overpayments by the Medicaid program.